Inactive Instrument
Mymetics Corporation Share Price Other OTC
Stocks
MYMX
US62856A1025
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 439K 385K 355K 332K 623K 41.4M 634K 4.26M 1.65M 20.41M 1.65M 1.61M 70.93M | P/E 2021 |
-1.86x | P/E 2022 | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 72.12M 63.35M 58.37M 54.58M 102M 6.81B 104M 700M 271M 3.35B 271M 265M 11.66B | EV / Sales 2021 |
177x | EV / Sales 2022 | 78x |
| Free-Float |
99.88% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 18/11/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.24% | +8.79% | - | - | 45 | |
| +4.43% | +2.49% | +61.83% | +115.25% | 55.35B | |
| +1.58% | +14.12% | +72.87% | +85.18% | 51.92B | |
| -0.23% | -0.98% | -14.12% | -16.00% | 22.76B | |
| +0.98% | +9.05% | -0.36% | +423.40% | 22.64B | |
| -0.60% | +6.90% | +31.44% | -14.54% | 17.36B | |
| +0.88% | +5.78% | +30.82% | -34.26% | 16.1B | |
| +3.02% | +12.74% | +143.33% | +308.04% | 13.96B | |
| +0.68% | +2.54% | +22.28% | +168.03% | 13.38B | |
| +1.02% | +5.76% | +27.69% | - | 12.27B | |
| Average | +0.09% | +5.82% | +41.75% | +129.39% | 25.08B | |
| Weighted average by Cap. | +1.79% | +6.54% | +46.76% | +120.72% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 430K 378K 348K 325K 610K 40.58M 621K 4.18M 1.62M 20M 1.61M 1.58M 69.51M | 1.03M 903K 832K 778K 1.46M 97M 1.49M 9.98M 3.87M 47.82M 3.86M 3.78M 166M |
| Net income | -4.73M -4.15M -3.83M -3.58M -6.71M -446M -6.84M -45.93M -17.79M -220M -17.76M -17.37M -765M | -4.8M -4.22M -3.89M -3.64M -6.82M -453M -6.94M -46.66M -18.07M -224M -18.04M -17.65M -777M |
| Net Debt | 67.1M 58.94M 54.3M 50.78M 95.23M 6.33B 96.98M 652M 252M 3.12B 252M 246M 10.85B | 71.68M 62.97M 58.01M 54.24M 102M 6.76B 104M 696M 270M 3.33B 269M 263M 11.59B |
Employees
-
